Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.
Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page
- CheckyesterdayChange DetectedRemoval of related topics entries for Melanoma and MedlinePlus Genetics from the study page, removing supplementary navigational items. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoChange DetectedThe study locations now total 23, with Murdoch, Western Australia (One Clinical Research Perth) listed. Updated dates and enrollment numbers are shown, and multiple contact details were removed.SummaryDifference5%

- Check15 days agoChange DetectedThe page now displays Revision: v3.3.2 and removes Revision: v3.3.1, indicating a metadata update. No study content, eligibility criteria, or results are changed.SummaryDifference0.0%

- Check23 days agoChange DetectedAdditions: a PubMed-based note stating that publications are automatically filled from PubMed, and a new Revision: v3.3.1. Deletions: removal of the older PubMed publication note and Revision: v3.2.0; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange Detected- The funding-status disclaimer about lapse in government funding has been removed from the page. The study details, contact information, and locations remain unchanged.SummaryDifference0.3%

- Check44 days agoChange DetectedMelanoma is added as a topic and a Related Topics link to MedlinePlus Genetics appears on the page.SummaryDifference0.5%

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.